Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-24 @ 10:51 PM
NCT ID:
NCT02175069
Eligibility Criteria:
Inclusion Criteria:
* Age between 18 and 75 years
* Surgery of the shoulder (shoulder arthroscopy, open shoulder joint surgery, rotator cuff surgery, tendon transfer, shoulder arthroplasty, humerus fracture surgery)
* Patients willing to undergo magnetic resonance imaging prior to surgery
* Informed consent to participate in the study
* American Society of Anesthesiologists physical score I, II or III
Exclusion Criteria:
* Refusal to participate in the study
* Inability to understand the study protocol due to language barrier
* Serious cardiac or pulmonary disease such as decompensated heart failure, recent myocardial infarction (less than one month in the past), heart block greater than 2nd degree, obstructive sleep apnea and chronic obstructive lung disease greater than 2nd degree
* renal impairment with an calculated glomerular filtration rate below 60ml/min
* Hypersensitivity to ropivacaine or gadolinium or other contraindications against peripheral nerve blocks
* Chronic opioid usage greater than 15 mg oral morphine equivalents daily, the daily use of adjunctive pain medications (gabapentins, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors)
* Schizophrenia or bipolar disorders, uncontrolled anxiety, claustrophobia
* Peripheral neuropathy
* Hepatic or renal impairment
* Ongoing illicit drug or alcohol abuse
* Metal implants or other contraindications for magnetic resonance imaging
* Coagulopathy
* Participation in additional clinical trials within 4 weeks before screening
* Hearing impairment
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02175069
Study Brief:
Protocol Section:
NCT02175069